These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32926602)

  • 1. Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.
    Kayser RR
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926602
    [No Abstract]   [Full Text] [Related]  

  • 2. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
    Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic management of obsessive-compulsive disorder.
    Jackson CW; Morton WA; Lydiard RB
    South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.
    Koran LM; Aboujaoude E; Ward H; Shapira NA; Sallee FR; Gamel N; Elliott M
    J Clin Psychopharmacol; 2006 Feb; 26(1):79-83. PubMed ID: 16415712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clomipramine in obsessive-compulsive disorder.
    Howland RH
    Anxiety; 1996; 2(1):56-7. PubMed ID: 9160602
    [No Abstract]   [Full Text] [Related]  

  • 6. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
    López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
    Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
    Baving L; Schmidt MH
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
    Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
    J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].
    Brochier T; Hantouche E
    Encephale; 1989; 15(3):325-33. PubMed ID: 8641159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of pharmacologic treatments for obsessive-compulsive disorder.
    Kaplan A; Hollander E
    Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Drug Ther Bull; 1995 Jun; 33(6):47-8. PubMed ID: 7587998
    [No Abstract]   [Full Text] [Related]  

  • 12. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J; Judge R
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.
    Iwata Y; Kotani Y; Hoshino R; Takei N; Iyo M; Mori N
    J Clin Psychiatry; 2000 Jul; 61(7):528-9. PubMed ID: 10937614
    [No Abstract]   [Full Text] [Related]  

  • 14. Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder.
    Kumar TC; Khanna S
    Aust N Z J Psychiatry; 2000 Jun; 34(3):527-8. PubMed ID: 10881981
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents.
    de Haan E; Hoogduin KA; Buitelaar JK; Keijsers GP
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1022-9. PubMed ID: 9785713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C; Freeston MH; Borgeat F
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
    Pittenger C
    Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case study: obsessive difficult temperament and its response to serotonergic medication.
    Garland EJ; Weiss M
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):916-20. PubMed ID: 8768352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-induced hypomania in obsessive-compulsive disorder.
    Rihmer Z; Barsi J; Belsõ N; Pestality P; György S
    Int Clin Psychopharmacol; 1996 Sep; 11(3):203-5. PubMed ID: 8923100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.